ArticleThe Eurasian journal of medicine2025
Comparison of Length of Treatment and Comorbidities in Older and Adult Hospitalized Patients with Bacterial Community-Acquired Pneumonia.
Article in The Eurasian journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antimicrobial Resistance and Clinical Outcome Among Hospitalized Bacterial Pneumonia: A Retrospective Cohort Study in Indonesian Tertiary Hospital.Antibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Among the 1 017 290 people surveyed, the prevalence of pneumonia was 2.5% in the 55-64 age group, 3.0% in the 65-74 age group, and 2.9% in those aged 75 years and older. This indicates an increase in pneumonia prevalence from 1.8% to 2% in Indonesia. This study aimed to compare the length of treatment and comorbidities in older and adult patients with community-acquired pneumonia at Jakarta Sukapura Islamic Hospital and Jakarta Pondok Kopi Islamic Hospital between September 2022 and September 2024. Methods: This was a comparative study with a cross-sectional design, and secondary data from 244 patient samples were used. Results: Among adult patients, 101 had a length of treatment of ≤5 days, whereas 17 had a length of treatment of >5 days. Among older patients, 67 had a length of treatment of ≤5 days, whereas 59 had a length of treatment of >5 days. Comorbidities were absent in 69 adult and 45 older patients. A total of 49 adult patients and 81 older patients had comorbidities. Conclusion: Older patients with community-acquired pneumonia had a longer treatment duration and more comorbidities than adult patients with bacterial community-acquired pneumonia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.